A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
מצבים רפואיים
Advanced or Metastatic Squamous Non-Small Cell Lung Cancer · Advanced Head and Neck Squamous Cell Carcinoma · Advanced Esophageal Squamous Cell Carcinoma · Cervical Squamous Cell Carcinoma · Advanced Cutaneous Squamous Cell Carcinoma · Nasopharyngeal Cancinoma (NPC) · Squamous Cell Carcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
GenesisCare North Shore, Sydney, New South Wales, Australia
Westmead Hospital, Westmead, New South Wales, Australia
Contact: Study coordinator (Pei Ding)Contact: Principal Investigator (Pei Dr Ding)ICON Cancer Centre South Brisbane, Brisbane, Queensland, Australia
Greenslopes Private Hospital, Greenslopes, Queensland, Australia
Contact: Study coordinator (Rahul Ladwa)Contact: Principal Investigator (Rahul Ladwa)Southern Oncology Clinical Research Unit, Adelaide, South Australia, Australia
Contact: Study coordinator (Ganessan Kichenadasse)Contact: Principal Investigator (Ganessan Kichenadasse)Peninsula & South Eastern Haematology and Oncology Group, Frankston, Victoria, Australia
Contact: Study coordinator (Vinod Ganju)Contact: Principal Investigator (Vinod Prof Ganju)Cabrini Health, Malvern, Victoria, Australia
Linear Clinical Research, Perth, Western Australia, Australia
Contact: Study coordinator (Samantha Bowyer)Contact: Principal Investigator (Samantha Bowyer)The Institute of Oncology, ARENSIA Exploratory Medicine Phase I Unit, Chisinau, Moldova
Contact: Study coordinator (Iurie Bulat)Contact: Principal Investigator (Iurie Bulat)National Cancer Centre Singapore, Singapore, Singapore
Contact: Study coordinator (Aaron Tan)Contact: Principal Investigator (Aaron Tan)Tan Tock Seng Hospital, Singapore, Singapore
Contact: Study coordinator (Jens Samol)Contact: Principal Investigator (Jens Samol)Chungbuk National University Hospital, Cheongju-si, South Korea
Contact: Study coordinator (Ki Hyeong Lee)Contact: Principal Investigator (Ki Hyeong Lee)CHA Bundang Medical Center, CHA University, Seongnam-si, South Korea
Contact: Study coordinator (Joo-Hang Kim)Contact: Principal Investigator (Joo-Hang Kim)Korea University Anam Hospital, Seoul, South Korea
Contact: Study coordinator (Yoon Ji Choi)Contact: Principal Investigator (Yoon Ji Choi)Severance Hospital, Seoul, South Korea
Contact: Study coordinator (Hye Ryun Kim)Contact: Principal Investigator (Hye Ryun Kim)The Catholic University of Korea St. Vincent's Hospital, Suwon, South Korea
Contact: Study coordinator (Byoung Yong Shim)Contact: Principal Investigator (Byoung Yong Shim)Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
Contact: Study coordinator (Jen-Yu Hung)Contact: Principal Investigator (Jen-Yu Hung)National Cheng Kung University Hospital, Tainan, Taiwan
Contact: Study coordinator (Chun-Hui Lee)Contact: Principal Investigator (Chun-Hui Lee)Taipei Medical University - Shuang Ho Hospital, Taipei, Taiwan
Contact: Study coordinator (Wei-Hong Cheng)Contact: Principal Investigator (Wei-Hong Cheng)Taipei Veterans General Hospital, Taipei, Taiwan
Contact: Study coordinator (Yuh-Min Chen)Contact: Principal Investigator (Yuh-Min Chen)